The IWMF is aware that the potential cost of novel oral medications such as IMBRUVICA® (ibrutinib) is a recent and growing concern to the WM community. The Johnson & Johnson Patient Assistance Foundation provides assistance to uninsured US patients who lack the financial resources to pay for certain medicines, including IMBRUVICA®. To see if you qualify, call the Johnson & Johnson Patient Assistance Foundation at 1-800-652-6227, or visit its website at www.jjpaf.org.
Patients with limited financial resources taking medications marketed by other pharmaceutical companies are encouraged to contact the financial assistance programs of those respective pharmaceutical companies – in many cases, some form of help is available for those in need. Assistance is also provided by non-profit foundations for WM patients who are insured but need help with drug co-pays. Visit the IWMF website for more information.